- Senator Amy Klobuchar, chair of the Senate Judiciary antitrust subcommittee, sent a letter to the Federal Trade Commission (FTC) regarding Amazon’s acquisition of One Medical. Klobuchar stated that the $3.9 billion deal “raises questions about potential anticompetitive effects related to the pharmacy services business Amazon already owns and about preferencing vendors who offer other services through Amazon.” (Article here)
July 25, 2022
M&A